ClinicalTrials.gov
ClinicalTrials.gov Menu

Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00600210
Recruitment Status : Withdrawn (low patient accrual)
First Posted : January 24, 2008
Last Update Posted : August 23, 2017
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Leo W. Jenkins Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : April 2011
  Actual Study Completion Date : April 2011
Publications: